Abduzhappar Gaipov is an expert in Nephrology at Nazarbayev University (Kazakhstan). As of October 2026, ScienceLeadR ranks Abduzhappar Gaipov in the top 1% of experts in Kazakhstan for Renal Insufficiency and Hypertension. Abduzhappar Gaipov has authored 272 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 930 (community average: 125). How the SLR is computed.

LeadR Profile

Abduzhappar Gaipov Nazarbayev University Kazakhstan
930 ScienceLeadR Reputation 930
Network Map

Nephrology

Subspecialties: Public Health - Biochemistry - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Nazarbayev University

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023.
PMID 42814432 — heart diseases, heart failure, heart, cardiovascular diseases, public health, global burden of disease, prevalence, cost of illness, chagas disease
JAMA Cardiol20260
Key determinants of self-management in patients with non-dialysis-dependent chronic kidney disease: a systematic review.
PMID 42454249 — kidney diseases, self-management, kidney, self care, health literacy, literacy
Public Health Rev20261
Gabapentinoids for Neuropathic Pain Management: A Systematic Umbrella Review.
PMID 42393894 — peripheral nervous system diseases, gabapentin, spinal cord, chronic pain, pain, pain management, neoplasms, spinal cord injuries, pregabalin, neuralgia, sleepiness, spine
Curr Neuropharmacol20260
Once-Weekly Subcutaneous Insulin Efsitora for the Management of Diabetes Mellitus: A Systematic Review and Meta-Analysis Study.
PMID 42383405 — diabetes mellitus, insulin, therapeutics, hypoglycemic agents, hypoglycemia, diabetes mellitus, type 1, glycemic control, diabetes mellitus, type 2
Medeni Med J20260
Extraoral Detection of Biomarkers and Pathogens in Saliva: Comprehensive, Panoramic Review.
PMID 42345901 — biomarkers, viruses, hydrocortisone, bacteria
Biosensors (Basel)20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3

By status:

Active not recruiting 1
Not yet recruiting 1
Recruiting 1

By type:

Observational 2
Interventional 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Preventive Use of PIPAC in Locally Advanced Gastric Cancer
NCT06784765 — stomach, incidence, lymph node excision, aerosols, doxorubicin, neoplasms, drug therapy, peritoneal neoplasms, therapeutics, gastrectomy, stomach neoplasms, chemotherapy, pressurized intraperitoneal aerosol chemotherapy
N/ARecruiting2025
Ventriculo Arterial Coupling and Intra Dialytic Changes in Hemodialysis Patients Prognostic Insights
NCT06622928 — hospitalization, myocardial infarction, heart failure, heart, kidney, echocardiography, kidney failure, chronic, software
N/ANot yet recruiting2024

LeadR Networks

Main global connection map